1
/
of
1
Elabscience
SKU:E-CL-H1046
Human PECAM1/CD31(Platelet/Endothelial Cell Adhesion Molecule 1) CLIA Kit
Human PECAM1/CD31(Platelet/Endothelial Cell Adhesion Molecule 1) CLIA Kit
Regular price
$682.00 USD
Regular price
Sale price
$682.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Human PECAM1/CD31 (Platelet/Endothelial Cell Adhesion Molecule 1) CLIA Kit, a cutting-edge solution designed to facilitate accurate and efficient analysis of PECAM1/CD31 levels in human samples. This advanced kit is meticulously crafted to cater to the needs of researchers and clinicians seeking to delve into the intricate world of platelet and endothelial cell adhesion.
With its state-of-the-art chemiluminescent immunoassay (CLIA) technology, this kit offers unparalleled sensitivity and specificity, enabling precise quantification of PECAM1/CD31 expression. By utilizing a highly specific antibody, this kit ensures minimal cross-reactivity, guaranteeing reliable and reproducible results.
The Human PECAM1/CD31 CLIA Kit boasts a user-friendly protocol, allowing for seamless integration into laboratory workflows. Its comprehensive package includes all necessary reagents and components, meticulously optimized to ensure optimal performance and accuracy. The kit's streamlined design minimizes the risk of errors, facilitating swift and efficient analysis.
This innovative kit is not only highly sensitive but also exhibits an impressive dynamic range, accommodating a wide spectrum of sample concentrations. Its versatility enables the analysis of various sample types, including serum, plasma, and cell culture supernatants, providing researchers with the flexibility needed to explore diverse experimental settings.
Furthermore, the Human PECAM1/CD31 CLIA Kit is backed by rigorous quality control measures, ensuring consistent and reliable results. Each batch undergoes meticulous testing to guarantee batch-to-batch consistency, minimizing variability and enhancing the reproducibility of experimental outcomes.
In summary, the Human PECAM1/CD31 CLIA Kit is a state-of-the-art solution that empowers researchers and clinicians to unravel the complexities of platelet and endothelial cell adhesion. With its exceptional sensitivity, specificity, and user-friendly design, this kit is poised to revolutionize the field of PECAM1/CD31 analysis, enabling groundbreaking discoveries and advancements in biomedical research.
With its state-of-the-art chemiluminescent immunoassay (CLIA) technology, this kit offers unparalleled sensitivity and specificity, enabling precise quantification of PECAM1/CD31 expression. By utilizing a highly specific antibody, this kit ensures minimal cross-reactivity, guaranteeing reliable and reproducible results.
The Human PECAM1/CD31 CLIA Kit boasts a user-friendly protocol, allowing for seamless integration into laboratory workflows. Its comprehensive package includes all necessary reagents and components, meticulously optimized to ensure optimal performance and accuracy. The kit's streamlined design minimizes the risk of errors, facilitating swift and efficient analysis.
This innovative kit is not only highly sensitive but also exhibits an impressive dynamic range, accommodating a wide spectrum of sample concentrations. Its versatility enables the analysis of various sample types, including serum, plasma, and cell culture supernatants, providing researchers with the flexibility needed to explore diverse experimental settings.
Furthermore, the Human PECAM1/CD31 CLIA Kit is backed by rigorous quality control measures, ensuring consistent and reliable results. Each batch undergoes meticulous testing to guarantee batch-to-batch consistency, minimizing variability and enhancing the reproducibility of experimental outcomes.
In summary, the Human PECAM1/CD31 CLIA Kit is a state-of-the-art solution that empowers researchers and clinicians to unravel the complexities of platelet and endothelial cell adhesion. With its exceptional sensitivity, specificity, and user-friendly design, this kit is poised to revolutionize the field of PECAM1/CD31 analysis, enabling groundbreaking discoveries and advancements in biomedical research.
Share
